Metabolic Regulation Peptides Bioactive Toxin-Derived Peptides Tumor-Associated Antigen Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Neurodegenerative Disease Research Peptides Melanogenesis Modulation Anti-Aging & Skin Remodeling Gastrin, GRP & Bombesin Peptides Somatostatin Analogs DPPIV/CD26 Peptides Kinase Activity Modulators Caspase Substrates & Inhibitors Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Calcitonin & CGRP Family Peptides Incretin & Metabolic Peptides Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Peptide Coupling Reagents & Additives Specialty Peptide Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Neuromodulatory and Neuroactive Peptides Neurotransmitters/Neuropeptides Substance P | RPKPQQFFGLM-NH2 NK1 Receptor Agonist

DESCRIPTION

Substance P is the endogenous 11-residue tachykinin Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2. It is the preferred endogenous agonist of the neurokinin-1 receptor, NK1/TACR1, and serves as a reference ligand in tachykinin receptor pharmacology.

Its biological activity depends on both the amidated hydrophobic C-terminal pharmacophore and contributions from the N-terminal sequence. Substance P is widely used in NK1 signaling, receptor binding, neuronal and smooth-muscle studies, peptide metabolism, and structure–activity comparisons with truncated or modified analogs.

Product Information

Product NameSubstance P
Catalog No.AS2721
CAS No.33507-63-0
SequenceArg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
One-Letter SequenceRPKPQQFFGLM-NH2
Peptide Length11 residues
Molecular FormulaC63H98N18O13S
Molecular WeightApproximately 1347.6 Da
C-TerminusAmidated
Primary TargetNK1 receptor / TACR1
Pharmacological ProfileEndogenous full agonist

Substance P Preferentially Activates NK1

Substance P is the preferred endogenous tachykinin ligand for NK1. Curated human receptor data report NK1 pKi values of approximately 8.5–10.3.

Affinity for NK2 and NK3 is substantially lower, although Substance P should not be described as absolutely receptor-specific at sufficiently high concentrations.

The Amidated C-Terminal Pharmacophore

The Phe-Phe-Gly-Leu-Met-NH2 sequence contributes strongly to tachykinin receptor recognition, while upstream residues enhance NK1 affinity and signaling.

Comparison with Substance P Free Acid demonstrates that C-terminal amidation is also a critical part of the active molecular structure.

Met11 Oxidation

Met11 can oxidize to methionine sulfoxide, producing a +16 Da mass shift. For quantitative signaling or receptor-binding experiments, we recommend monitoring peptide integrity when comparing old solutions, repeated freeze-thaw samples or different lots.

Research Applications

Substance P can support NK1 receptor pharmacology, second-messenger signaling, neuronal and smooth-muscle research, peptide metabolism and tachykinin SAR.

Custom Substance P analogs, non-natural amino acids and project-specific modifications are available through our Chemical Peptide Synthesis service.

Frequently Asked Questions

What is the sequence of Substance P?

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2.

What is its primary receptor?

NK1, also called TACR1.

Is Substance P completely selective for NK1?

No. It strongly prefers NK1 but can interact with other tachykinin receptors at higher concentrations.

Why is the C-terminal amide important?

Amidation is a critical structural feature of the active tachykinin pharmacophore.

Should Met11 oxidation be monitored?

Yes. Oxidation creates a +16 Da mass shift and can introduce chemical heterogeneity.

Research Use Only.

Substance P | RPKPQQFFGLM-NH2 NK1 Receptor Agonist

Catalog No: AS2721
Cas No: 33507-63-0

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit